Data as of Apr 17
| +0.2099 / +3.81%|
The 1 analysts offering 12-month price forecasts for Skystar Bio-Pharmaceutical Co have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a -56.29% decrease from the last price of 5.72.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.